Graves Disease Clinical Trials

31 recruitingLast updated: June 17, 2026

There are 31 actively recruiting graves disease clinical trials across 29 countries. Studies span Not Applicable, Phase 2, Early Phase 1, Phase 1, Phase 4, Phase 3. Top locations include Gothenburg, Sweden, Shanghai, Shanghai Municipality, China, Dallas, Texas, United States. Updated daily from ClinicalTrials.gov.


Graves Disease Trials at a Glance

31 actively recruiting trials for graves disease are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Gothenburg, Shanghai, and Dallas. Lead sponsors running graves disease studies include Vastra Gotaland Region, Shanghai Zhongshan Hospital, and Immunovant Sciences GmbH.

Browse graves disease trials by phase

Treatments under study

About Graves Disease Clinical Trials

Looking for clinical trials for Graves Disease? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Graves Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Graves Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 2

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves Disease
Immunovant Sciences GmbH210 enrolled145 locationsNCT07018323
Recruiting

Evaluating an AI Tool for Detecting Thyrotoxic States

Graves DiseaseHyperthyroidism/Thyrotoxicosis
THYROSCOPE INC.15 enrolled1 locationNCT07017907
Recruiting
Phase 1

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

Graves Disease
Merida Biosciences100 enrolled8 locationsNCT07305818
Recruiting
Phase 2

A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

Graves Disease
Sanofi30 enrolled13 locationsNCT06984627
Recruiting
Phase 2

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves Disease
Immunovant Sciences GmbH240 enrolled134 locationsNCT06727604
Recruiting
Phase 1

Study of BHV-1300 in Graves' Disease

Graves Disease
Biohaven Therapeutics Ltd.15 enrolled17 locationsNCT06980649
Recruiting
Early Phase 1

In Vivo CAR-T for Refractory Graves' Disease

Graves Disease
Shanghai Zhongshan Hospital5 enrolled1 locationNCT07333677
Recruiting

Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease

Graves DiseaseGraves Ophthalmopathy
Elazıg Fethi Sekin Sehir Hastanesi100 enrolled1 locationNCT07480720
Recruiting
Phase 1

A Study of GensSci098 in Subjects With Graves' Disease

SafetyGraves DiseaseTolerability+1 more
Changchun GeneScience Pharmaceutical Co., Ltd.24 enrolled1 locationNCT07286656
Recruiting
Not Applicable

Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Thyroid CancerGraves Disease
University of Ulm60 enrolled1 locationNCT07410637
Recruiting
Phase 2

Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

Graves DiseaseHyperthyroidism
Northwell Health30 enrolled1 locationNCT07369063
Recruiting
Early Phase 1

Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease

Graves Disease
Shanghai Zhongshan Hospital4 enrolled1 locationNCT07261345
Recruiting
Not Applicable

Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules

Graves DiseaseThyroid Nodule \(Benign\)Goitre
Royal Berkshire NHS Foundation Trust10 enrolled1 locationNCT07046546
Recruiting
Not Applicable

The Impact of Person Centred Care (PCC) in Grave's Disease

Graves Disease
Vastra Gotaland Region220 enrolled1 locationNCT06309316
Recruiting
Not Applicable

Course for Brain Fatigue After Graves' Disease Controlled Study

Graves Disease
Vastra Gotaland Region96 enrolled1 locationNCT06134219
Recruiting
Not Applicable

Personalized Treatment in Thyroid Disorders

Thyroid CancerGraves Disease
Johns Hopkins University10 enrolled1 locationNCT03517579
Recruiting

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Graves DiseaseThyroid DiseasesAutoimmune Diseases+2 more
Vastra Gotaland Region180 enrolled1 locationNCT05678374
Recruiting
Not Applicable

Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease

Graves Disease (Basedow's Disease)
Betul Uner42 enrolled1 locationNCT07164079
Recruiting
Not Applicable

Prospective Evaluation of OptiThyDose

Graves DiseaseThyroid DiseasesCongenital Hypothyroidism
University Children's Hospital Basel150 enrolled2 locationsNCT06864351
Recruiting
Early Phase 1

Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease

Graves Disease
Shanghai Zhongshan Hospital5 enrolled1 locationNCT07129642